highly significantp < 0.001
Both the Cis + BM200 and Cis + BM300 groups exhibited reductions in ALP, AST, and ALT levels relative to the cisplatin group, with all three enzymes showing highly significant differences (p < 0.001).
Both the Cis + BM200 and Cis + BM300 groups exhibited reductions in ALP, AST, and ALT levels relative to the cisplatin group, with all three enzymes showing highly significant differences (p < 0.001).